Novalis Biotech — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Enzyreenzyre.comNov 2022
Enzyre develops a handheld diagnostic device that performs multiple blood coagulation assays in parallel to identify bleeding causes at the point of care.
BiotechDeep TechDigital HealthHealthtechMedical DevicesEindhoven, NL
Wim van den Broek(CEO)inWaander(CSO)
Co-investorsi&i Biotech FundOost NLTakeda Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.